# Long-term Sedation With Remimazolam Besylate in Critically Ill Patients

> **NCT05555667** · PHASE3 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 728 (estimated)

## Conditions studied

- Light Sedation
- Mechanical Ventilation

## Interventions

- **DRUG:** Remimazolam besylate
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05555667
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-16
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 728 (ESTIMATED)
- **Last updated:** 2023-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05555667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05555667, "Long-term Sedation With Remimazolam Besylate in Critically Ill Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05555667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*